| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |